Business Phone Number: 86-20-83827812-10401
Business Email: maguixian@gdph.org.cn
Place of Birth: Guangdong, P.R. China
Languages: Mandarin, Cantonese, Chaozhou dialect
Specialties: Interventional treatment, Stroke
Departments: Neurology
Research Interests: Stroke and Traumatic Brain Injury
Education
|
09/2013-07/2018 |
PHD |
Medical Science |
Guangdong Cardiovascular Institute , Guangdong, China |
|
09/2016-10/2017 |
|
VisitingFellow |
Boston Children's Hospital, Harvard Medical School |
|
11/2012 |
|
Neurology Subspecialty Training Course |
Melbourne, Australia |
|
09/2004-07/2007 |
M. Med |
Medical Science |
Guangdong Cardiovascular Institute , Guangdong, China |
|
09/1995-07/2000 |
B. Med |
Clinical Medicine |
Guangdong Medical College,Guangdong, China |
Honors and Prizes
Second Prize of Guangdong Province Science and Technology Progress Award(2011): The study of endovascular interventional diagnosis and therapy technology as the core of comprehensive treatment system in patients with ischemic stroke(No.B14-0-2-02-R05)
Publications
1. Guixian Ma, Changyun Liu, Jumana Hashim, Grace Conley, Nicholas Morriss, William P. Meehan III, Jianhua Qiu, Rebekah Mannix. Memantine mitigates oligodendrocyte damage after repetitive mild traumatic brain injury.Neuroscience,2019;421:152-161.
2.Wang Lijuan, Zis Odysseus, Ma Guixian(contributed equally), Shan Zhixin, Zhang Xiong, Wang Shuo, Dai Chengbo, Zhao Jiehao, Lin Qiuxiong, Liu Xingtong, Lin Shuguang, and Song Weihong. Upregulation of macrophage migration inhibitoryfactor (MIF) gene expression in stroke. Stroke, 2009;40, 973-976.
3. Liu Xintong, Wang Wei, Tang Zhoupin, Zeng Wengao, He Chizhong, Wang Lijuan, Lu Haike, Li Chuanmao, Zhang Xiong, Wang Shou, Dai Chengbo, Ma Guixian, Yang Zhexian, Ma Tengyun. Clinical study of PTAS therapy for patients with ischemia cerebrovascular disease caused by artery stenosis. J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):67-72.
4. Wu Yijuan, Wang Lijuan, Dai Chengbo, Ma Guixian, Zhang Yuhu, Zhang Xiong, Wu Zhuohua. Neuroprotection by platelet-activating factor acetylhydrolase in a mouse model of transient cerebral ischemia. Neurosci Lett. 2014 Jan 13;558:26-30.
5. Nie K, Feng SJ, Tang HM, Ma GX, Gan R, Zhao X, Zhao JH, Wang LM, Huang ZH, Huang J, Gao L, Zhang YW, Zhu RM, Duan ZP, Zhang YH, Wang LJ. RIT2 polymorphism is associated with Parkinson's disease in a Han Chinese population. Neurobiol Aging. 2015 Mar;36(3):1603.e15-7.
6. Li H, Zhou S, Wu L, Liu K, Zhang Y, Ma G, Wang L. The role of p38MAPK signal pathway in the neuroprotective mechanism of limb postconditioning against rat cerebral ischemia/reperfusion injury. J Neurol Sci. 2015 Oct 15;357(1-2):270-275.
7. Zhang G, Zhang Y, Zhang C, Wang Y, Ma G, Nie K, Xie H, Liu J, Wang L. Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease. Parkinsons Dis. 2015;2015:207624.
8. Li Wang, Kun Nie, Xin Zhao, Shujun Feng, Sifen Xie, Xuetao He, Guixian Ma, Limin Wang, Zhiheng Huang, Biao Huang, Yuhu Zhang, Lijuan Wang. Characteristics of gray matter morphological change in Parkinson’s disease patients with semantic abstract reasoning deficits. Neuroscience Letters, 2018;673, 85-91.
9. Gao Yuyuan, Nie Kun, Duan Zhenpeng, Wang Shuo, Ma Guixian, Zhang Xiong, Li Changmao, Zhang Yuhu, Dai Chengbo*, Wang Lijuan*. A Follow-up Study of Cerebral Microbleeds in Patients Who Received Stents for Symptomatic Cerebral Artery Stenosis. Annals of Vascular Surgery. 2019;58:338-346.
